In future studies, we plan to perform experiments such as qPCR and Western blot to verify the expression changes of MAN2A2, TNFRSF12A, SPP1, CSNK1D, PLAUR, PFKFB3, and CXCL16, as well as microRNAs that might target the DEGs in experimental models of MI and clinical samples. The gene discussed is CXCL16; the disease is myocardial infarction.